Nonemergent Treatment of Hypertension
作者： William C. Cushman , Edward D. Freis
DOI: 10.1007/978-1-4612-4864-4_10
关键词: Beta blocker 、 Diastole 、 Affect (psychology) 、 Public health 、 Population 、 Scope (project management) 、 Pharmacotherapy 、 Emergency medicine 、 Blood pressure 、 Medicine
摘要: Hypertension, as defined by a blood pressure (BP) of 140 mm Hg or higher systolic 90 diastolic at single examination, is said to affect 25% (60 million) the population United States (1,2). Approximately 30–50% these individuals, however, will be normotensive on subsequent determinations (3,4). Nevertheless, over 30 million Americans would still classified hypertensive according 1984 recommendations Joint Rational Committee Detection, Evaluation, and Treatment High Blood Pressure, that is, above mentioned BP criteria more than one visit (5). The prospect lifelong drug therapy for such high proportion presents public health cost considerations continue generate controversy, especially they pertain mildest forms hypertension. scope this chapter does not permit thorough discussion but we briefly review rationale our treatment
springer.com
sci-hub.st 参考文章(127)
Barry J. Materson, James R. Oster, Ulrich F. Michael, Sanford M. Bolton, Zeb C. Burton, John E. Stambaugh, John Morledge, Dose response to chlorthalidone in patients with mild hypertension; Efficacy of a lower dose Clinical Pharmacology & Therapeutics. ,vol. 24, pp. 192- 198 ,(1978) , 10.1002/CPT1978242192
Fagard R, MacFarlane Jp, Birkenhäger W, Forte J, Clement D, Bulpitt C, Hamdy R, Lund-Johansen P, Forette F, Amery A, De Schaepdryver A, Dollery C, Tuomilehto J, Deruyttere M, Mutsers A, Leonetti G, O'Malley K, Influence of anti-hypertensive therapy on serum cholesterol in elderly hypertensive patients. Results of trial by the European Working Party on High blood pressure in the Elderly (EWPHE). Acta Cardiologica. ,vol. 37, pp. 235- 244 ,(1982)
A. Amery, C. Bulpitt, A.De Schaepdryver, R. Fagard, J. Hellemans, A. Mutsers, P. Berthaux, M. Deruyttere, C. Dollery, F. Forette, P. Lund-Johansen, J. Tuomilehto, GLUCOSE INTOLERANCE DURING DIURETIC THERAPY The Lancet. ,vol. 311, pp. 681- 683 ,(1978) , 10.1016/S0140-6736(78)90797-3
Anders Helgeland, Paul Leren, Olav Per Foss, Ingvar Hjermann, Ingar Holme, Per G. Lund-Larsen, Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study. The American Journal of Medicine. ,vol. 76, pp. 802- 805 ,(1984) , 10.1016/0002-9343(84)90990-2
Edward D. Freis, Barry J. Materson, Walter Flamenbaum, Comparison of propranolol or hydrochlorothiazide alone for treatment of hypertension The American Journal of Medicine. ,vol. 74, pp. 1029- 1041 ,(1983) , 10.1016/0002-9343(83)90812-4
G. Greenberg, Comparison of the Antihypertensive Efficacy and Adverse Reactions to Two Doses of Bendrofluazide and Hydrochlorothiazide and the Effect of Potassium Supplementation on the Hypotensive Action of Bendrofluazide: Substudies of the Medical Research Council's The Journal of Clinical Pharmacology. ,vol. 27, pp. 271- 277 ,(1987) , 10.1002/J.1552-4604.1987.TB03012.X
Priscilla Kincaid-Smith, Beta-adrenergic receptor blocking drugs in hypertension The American Journal of Cardiology. ,vol. 53, pp. A12- A15 ,(1984) , 10.1016/0002-9149(84)90828-2
R J Kerry, J M Ludlow, G Owen, Diuretics are dangerous with lithium. BMJ. ,vol. 281, pp. 371- 371 ,(1980) , 10.1136/BMJ.281.6236.371
Cristobal G. Duarte, John L. Winnacker, Kenneth L. Becker, Angelo Pace, Thiazide-induced hypercalcemia. The New England Journal of Medicine. ,vol. 284, pp. 828- 830 ,(1971) , 10.1056/NEJM197104152841506
P. D. Levinson, Persistence of normal BP after withdrawal of drug treatment in mild hypertension. JAMA Internal Medicine. ,vol. 142, pp. 2265- 2268 ,(1982) , 10.1001/ARCHINTE.142.13.2265